Steve Scalise, House Majority Leader, to receive stem cell transplant

US House Majority Leader Steve Scalise is set to undergo a stem cell transplant, according to an announcement from his office on Friday. This decision comes after Scalise revealed in April 2023 that he had been diagnosed with blood cancer and had commenced treatment. Following the completion of induction chemotherapy and a positive response, it has been determined that Scalise is eligible for an autologous stem cell transplant. The procedure is expected to keep him out of Washington and working remotely until February, with Scalise recovering under the supervision of his medical team.

This latest development marks a significant milestone in Scalise’s battle against cancer. The news of his diagnosis earlier this year shocked many, as Scalise has been a prominent figure in the Republican Party and has held the position of House Majority Leader since 2014. His absence from Washington is expected to impact the Republican Party’s legislative agenda in the coming months. However, Scalise’s office remains optimistic about his recovery and eventual return to his duties in Washington. This story is currently developing, and further updates are anticipated.

Help improve our content system

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

Share this story:

Transplant News
Transplant News

Transplant News brings you the news and content that matters to the transplant community. From patient stories, to the latest in transplant innovation, Transplant News is your window into the world of transplantation.